Print 12 February 2013
Brian Dovey, Partner, Domain Associates LLC (one of the first venture capital firms to exclusively invest in the life sciences sector) - speaking about VC (Rusnanotech 2011)
The RMI group has completed sertain projects
The RMI Group has exited from the capital of portfolio companies:
Marinus Pharmaceuticals, Inc.,
Syndax Pharmaceuticals, Inc.,
Atea Pharmaceuticals, Inc.